Participating companies


We are proud to present an overview of participating companies at the conference. Companies will be active at our Industry fair, and some will also give talks (see program). For more information on each company, follow link to company websites.




Accenture is a leading global professional services company, providing a broad range of services and solutions in strategy, consulting, digital, technology and operations. Combining unmatched experience and specialized skills across more than 40 industries and all business functions - underpinned by the world’s largest delivery network - Accenture works at the intersection of business and technology to help clients improve their performance and create sustainable value for their stakeholders.

With approximately 425,000 people serving clients in more than 120 countries, Accenture drives innovation to improve the way the world works and lives.





Novartis is a healthcare company that provides solutions to address the evolving needs of patients worldwide. Its mission is to discover new ways to improve and extend people’s lives. Our vision is to be a trusted leader in changing the practice of medicine. Novartis is strongly dedicated to research, development and accessibility of medicines within a wide range of therapeutic areas including immunology, oncology, dermatology, cardiology, ophthalmology, pulmonology and neurology.

Novartis was created in 1996 through the merger of Ciba-Geigy and Sandoz and has a rich history spanning over 200 years. Our HQ is in Basel, Switzerland with strong global presence including offices in all Nordic countries.




Acarix (DK)

Acarix works to revolutionize cardiac diagnostics. Based on pioneering research performed at the Aalborg University, Acarix has developed a modern tool for early and accurate CAD rule-out, making decision-making for medical personnel easier and reducing onward referrals. See Acarix website.


GE Healthcare_400x400.png


GE Healthcare

GE Healthcare is an global manufacturer and distributor of diagnostic imaging agents, medical diagnostic equipment including CT image machines, and healthcare technological solutions for medical imaging and information technologies.





Pfizer Inc. is an American global pharmaceutical corporation headquartered in New York City. It is among the world’s largest pharmaceutical companies. Pfizer develops and produces medicines and vaccines for a wide range of medical disciplines, including immunology, oncology, cardiology, diabetology/endocrinology, and neurology. Pfizer has made numerous acquisitions and made more than 140 new research and development collaborations in 2016. Pfizer’s research and development department includes over 10.000 employers and have an annual budget > 7.9 billion $.
The External Science and Innovation department is responsible for identifying and establishing relationships with key external partners to capitalize on complementary areas of expertise. Through these collaborations, ESI creates unique opportunities for Pfizer researchers and partners to drive the discovery and development of potential new therapies that address areas of high unmet medical need.


Sarsia Seed.jpg


Sarsia Seed

Sarsia Seed is a Norwegian investment fund investing in early phase development science-based companies within the LifeScience, CleanTech and Energy –sectors. The fund is based on joint investments by the Norwegian Government and private investors where the Government has invested 50% and private investors 50%. From its first fund, Sarsia Seed has invested in 22 Norwegian companies in early development phase. 

Sarsia Seed was the first investor in newly listed BerGen Bio and in Vaccibody. Five of the companies in the Sarsia Seed pharma portfolio are either in clinical trials or on their way into such trials. Sarsia Seed has just recently opened its second fund for new investments and have so far made two investments from this fund. It is expected that the fund will invest in 8-10 additional companies.



Transfer Tech Office


Inven2 is a Tech Transfer Office owned by the University of Oslo and Oslo University Hospital. We make a difference by transforming research and knowledge from our owners into products and services that benefit society. Inven2 is the next-generation innovation company, established to maintain and develop Norwegian innovations, and bridge excellent research with the next generation technology-based industry.

Read more on Inven2 website.



Kjeller Vindteknikk_400x400.jpg


Kjeller Vindteknikk

Kjeller Vindteknikk (KVT) is one of the leading companies in measurements, analysis, and modeling of wind in the Nordic countries. They perform complete turn-key installation of meteorological masts, Lidar and Sodar systems. Other services include energy yield assessments and analysis adapted to the different development stages of a wind power project.

KTV has extensive experience from a large number of wind power projects in Europe. Currently, eight PHDs are working at KTV. Visit their website here.



Life Science


Bayer is a German Life Science company with a more than 150-year history and core competencies in the areas of health care and agriculture. Bayer is the only global company simultaneously researching improvements in human, animal and plant health. Systematic and intensive collaboration among researchers beyond their original specialization is providing new impetus. From world-renowned pharmaceutical products to high-tech platforms, from innovative diagnostics technologies to veterinary medicines – Bayer lives an innovation culture across national borders and areas of research.

In 2014, Bayer acquired Norwegian company Algeta and today over 150 employees are working out of their Norwegian HQ at Drammensveien 288.




Respinor is developing an ultrasound sensor for continuous monitoring of the diaphragm, the main breathing muscle. Our technology has a broad range of potential benefits and represents a technology platform for applications in critical care and in respiratory medicine.

The novelty of the device lies in the usage of a small ultrasound transducer in a highly specialized probe design that can be fixed to the skin surface using a patented, disposable, adhesive solution. The device is easy to use and allows for continuous monitoring of diaphragm excursion and respiratory rate. A set of observational studies are ongoing and a CE-marked product will be ready mid 2018 to be used in the H2020 funded randomized clinical trial.


Torheim pharmaceuticals_400x400.jpg


Torheim Pharmaceuticals

Torheim Pharmaceuticals(TP) was established in 2011, and has since been working with stakeholders in the life science sector to develop and implement new products and services. TP work with startups and multinationals alike, and support innovation and development processes - every step of the way from idea to market. Its primary focus is on commercialization of research-based ideas. In collaboration with other independent consultants, TP is currently establishing the Life Science Consulting Group, with the ambition to contribute to the development of a competitive life science industry in Norway and Scandinavia.

Bioco Medico_400x400.png


Bioco Medico (DK)

Bioco Medico is a spin out company based on research conducted at iNANO, Aarhus University. Inspired by nature and biological solutions, we develop the next generation adhesive materials from our technology platform.

Our adhesives are biocompatible, have tunable properties and work in wet conditions. This opens up for completely new use of adhesives in multiple industries. Our main focus is in the medical sector, developing new medical adhesives for wound closure and surgical procedures. 

Read more on Bioco Medico website.





SINTEF is a broad, multidisciplinary research organisation with international top-level expertise in the fields of technology, the natural sciences, medicine and the social sciences. We conduct contract R&D as a partner for the private and public sectors, and we are one of the largest contract research institutions in Europe.

Our vision is Technology for a better society. Visit SINTEF website for more information.



Indestro (US)

Indestro is a boutique consulting firm providing innovation consulting accelerator services for Fortune-1000 and technical universities.

Emrah Yalaz is the founder of Indestro. He has two decades of startup, product design and early-stage investment experience working as a VP of product, investor and academic. 

Read more about Indestro at




Ably Medical

Ably Medical is an innovation company that combines insight from big data, machine learning and ergonomics to design sustainable and cost-effective solutions for the healthcare industry’s most pressing problems. Our first product, the Ably Bed, is set to start its first clinical trial in April 2018 in Ontario, Canada and we hope to start sales of the Ably Bed by the start of 2019.

Ably Medical is currently comprised of 13 passionate individuals and we are looking to continue to keep expanding. Therefore, we would like to invite all of those with a strong background in Computer Science, especially with digital signal processing, machine learning or artificial intelligence, to come speak with us during the Industry Fair.


ACD Pharma_400x400.png


ACD Pharma

ACD Pharma is a small R&D company whose primary focus is innovations improving health, welfare and sustainability in aquaculture farming. Current projects include the development of bacteriophages as an alternative to antibiotics in aquaculture, and the production of reproductively sterile fish by a non-transgenic gene silencing technology.

The company is part of the Nordly Group, with sister companies in fish feed and medicinal feed production, sales and distribution of pharmaceuticals as well as veterinary and environmental services aimed at the aquaculture industry.





Otivio's core technology enables increased blood flow to the limbs of a patient. Our main product, FlowOx™, is addressing chronic wounds with focus on peripheral arterial disease (PAD), which is a serious condition leading to pain, chronic wounds and in many cases amputation and mortality. The patient population is very large and increasing.

There are limited adequate treatment options offered to the patients aside from surgical interventions. FlowOx™ is a non-invasive product intended for home use. Long-term patient testing in more than 50 patients documents increased blood flow, reduced pain and wound healing. FlowOx™ is CE marked.





Tieto is focused on integrated Lifecare – a seamless care and service chain from birth to old age. In the concept of Nordic well-being, health and social care outcomes are interdependent: social care factors influence the total care experience.

Tieto aims to become customers’ first choice for business renewal as the leading Nordic software and services company. Their aim is to capture the significant opportunities of the data-driven world and turn them into lifelong value for people, business and society.

Read more about Tieto at

Sopra Steria_400x400.jpg


Sopra Steria

Sopra Steria, a European leader in digital transformation, provides one of the most comprehensive portfolios of end-to-end service offerings on the market: consulting, systems integration, software development, infrastructure management and business process services.

Sopra Steria is trusted by leading private and public-sector organisations to deliver successful transformation programmes that address their most complex and critical business challenges. Combining high quality and performance services, added value and innovation, Sopra Steria enables its clients to make the best use of digital technology.